Nanox Imaging Ltd. (NASDAQ: NNOX), through its U.S.-based subsidiary Nanox Impact Inc., has entered into a distribution agreement with Associated X-Ray Imaging Corp. to support the deployment of the Nanox.ARC across New England. The agreement underscores Nanox’s commitment to expanding access to its innovative imaging technology beyond traditional hospital settings, targeting outpatient and community-based clinical environments.
Under the terms of the agreement, Associated X-Ray Imaging will market, distribute, and support the FDA-cleared, multisource 3D digital tomosynthesis system. Leveraging its established regional customer relationships and service infrastructure, Associated X-Ray Imaging is well-positioned to facilitate the adoption of Nanox.ARC in the region. This partnership is a strategic move to enhance the availability of advanced imaging solutions in areas that may have limited access to such technology.
The expansion of Nanox’s U.S. channel partner network is a critical component of the company’s broader strategy to drive the world’s transition to preventive healthcare. By integrating affordable imaging hardware with advanced AI-based solutions, cloud-based software, and comprehensive health IT services, Nanox aims to lower barriers to adoption and improve utilization of medical imaging. The Nanox ecosystem includes the Nanox.ARC system, designed for ease of use and scalability; Nanox.AI, which augments routine CT imaging interpretation; Nanox.CLOUD for secure data management; and Nanox.MARKETPLACE and USARAD Holdings for remote radiology services.
The agreement with Associated X-Ray Imaging is expected to increase access to the Nanox.ARC in targeted markets across New England. This move aligns with Nanox’s vision to expand the reach of medical imaging both within and beyond traditional hospital settings, providing a seamless solution from scan to interpretation. By leveraging proprietary digital X-ray technology and AI-driven analytics, Nanox seeks to enhance the efficiency of routine imaging workflows, support early detection of disease, and improve patient outcomes.
For more information about Nanox and its latest developments, visit the company’s newsroom at http://nnw.fm/NNOX. The full press release can be viewed at https://nnw.fm/ChGtd.
